Researchers from the McKelvey School of Engineering and Washington University School of Medicine in St. Louis are one step closer to delivering precise amounts of medication to exact location, repurposing an existing imaging "painting" method.
EPFL chemists have developed a new iron-nickel oxide catalyst for water splitting, the reaction that produces hydrogen fuel. The patent-pending catalyst shows significantly higher activity in the oxygen-evolution part of reaction than conventional nickel iron oxide catalysts. The work is now published in ACS Central Science.
Directed evolution is a powerful technique for engineering proteins. EPFL scientists now show that it can also be used to engineer synthetic nanoparticles as optical biosensors, which are used widely in biology, drug development, and even medical diagnostics such as real-time monitoring of glucose.
In the new study, the authors aimed to reprogram rapamycin by keeping the parts of rapamycin and tacrolimus that bind FKBP12 and changing the remaining half of the molecule in order to target completely new disease-associated proteins beyond mTOR and calcineurin.
A new Imperial-led review has outlined how health workers could use existing phones to predict and curb the spread of infectious diseases.
UC Berkeley synthetic biologists have created an enzymatic network in yeast that turns sugar into cannabinoids, including tetrahydrocannabinol and cannabidiol, but also novel cannabinoids not found in the marijuana plant itself. The yeast factories would be more environmentally friendly and less energy intensive than growing the plant and separating out the psychoactive and non-psychoactive ingredients. They may also yield cannabinoid derivatives with unexpected medical uses.
Researchers in the Syracuse University College of Engineering and Computer Science have developed a material -- a new kind of shape memory polymer (SMP) -- that could have major implications for health care.
Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
A team of engineers in the McKelvey School of Engineering has developed a high-powered fuel cell that operates at double the voltage of today's commercial fuel cells. It could power underwater vehicles, drones and eventually electric aircraft at a significantly lower cost.
A 3D hydrogel created by researchers at U of T Engineering is helping University of Ottawa researchers to quickly screen hundreds of potential drugs for their ability to fight highly invasive cancers.